Status unknownNCT02870374ReTransQolUpdated Aug 17, 2016

For a Better Interpretation of Quality of Life Scores of Kidney Transplant Patients: Determination of the Minimum Significant Change RetransQol

An observational study in Kidneys Transplantation, sponsored by Assistance Publique Hopitaux De Marseille. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-08-17.

Sponsored by Assistance Publique Hopitaux De Marseille · Observational

The sponsor has not verified this record recently (last verified Aug 2016), so the status shown — last known as Active, not recruiting — may be out of date.

Study type: Observational
Model: Case-only
Time perspective: Prospective
Enrollment: 2,000
Ages: 18 Years and older
Sex: All

Study summary

The project team developped and validated a French patient-based health-related quality of life instrument in kidney transplant: the QoL Retrans.

The aim of the study is to determine the minimum significant change of the valdiated tool: ReTransQol

Conditions studied

Kidneys Transplantation

In context

Lead sponsor

Assistance Publique Hopitaux De Marseille is the lead sponsor of 686 studies on the registry; 148 are open to participants now.

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: 18 Years and older
Sexes eligible: All
Accepts healthy volunteers: No
Sampling method: Probability sample

Study population

Kidneys transplanted patients

Inclusion criteria

Patient with a transplant kidney

Exclusion criteria

Exclusion Criteria:

Patient not able to answer survey

Study design

Observational model: Case-only
Time perspective: Prospective
Enrollment: 2,000 participants (estimated)
Patient registry: No

Interventions

BehavioralAnswering specific quality of life questionnaire in kidneys transplantation population

What researchers measure

Primary outcomes

Number of change in quality of life in kidneys transplantation patients using ReTransQol
Time frame: 1 year

Study locations

1 site

Assistance Publique Hôpitaux de Marseille
Marseille, 13354, France

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

Updates

Tracking since Sep 25, 2026

No changes since tracking began. The registry record was last updated on Aug 17, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT02870374
Lead sponsor: Assistance Publique Hopitaux De Marseille
Responsible party: Sponsor
First posted: Aug 17, 2016
Start date: Jan 2012
Primary completion: Mar 2015
Completion: Jan 2017 (estimated)
Last update: Aug 17, 2016

Study contacts

Urielle DESALBRES

study director · Assistance Publique Hôpitaux de Marseille

Stéphanie GENTILE, MD/PhD

principal investigator · Assistance Publique Hôpitaux de Marseille

Oversight

Data monitoring committee: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Assistance Publique Hopitaux De Marseille

Start the discussion